Core Viewpoint - Sanfu New Technology (688359.SH) reported a revenue of 621 million yuan for 2024, marking a year-on-year growth of 24.90%, while the net profit attributable to shareholders was -12.58 million yuan, an improvement from -36.79 million yuan in the previous year [1][3]. Financial Performance - The company's operating income for 2024 was 621.25 million yuan, up from 497.41 million yuan in 2023, reflecting a growth of 24.90% [3]. - The net profit attributable to shareholders for 2024 was -12.58 million yuan, compared to -36.79 million yuan in 2023, indicating a significant reduction in losses [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -28.95 million yuan for 2024, an improvement from -48.60 million yuan in 2023 [3]. - The net cash flow from operating activities was -65.16 million yuan in 2024, worsening from -22.85 million yuan in the previous year [3]. Quarterly Performance - In Q1 2025, the company reported an operating income of 12.53 million yuan, a decline of 32.67% year-on-year [4]. - The net profit attributable to shareholders in Q1 2025 was 5.41 million yuan, down 64.54% compared to the same quarter last year [4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q1 2025 was 4.14 million yuan, showing a significant increase of 154.86% year-on-year [4]. - The net cash flow from operating activities in Q1 2025 was 30.01 million yuan, a notable improvement from -22.96 million yuan in the same period last year [4]. Initial Public Offering (IPO) Details - Sanfu New Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on May 21, 2021, with a public offering of 23.05 million shares, representing 25% of the total share capital post-IPO [5][6]. - The IPO raised a total of 254 million yuan, with a net amount of 203 million yuan after deducting issuance costs, which was 57.14 million yuan less than the original plan [5]. - The issuance costs amounted to 51.34 million yuan, including underwriting fees of 36.51 million yuan [6].
三孚新科近3年均亏 2021年上市募2.54亿国联民生保荐